EP 3060220 A1 20160831 - COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
Title (en)
COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
Title (de)
ZUSAMMENSETZUNGEN ZUR ORALEN VERABREICHUNG VON ZOLEDRONSÄURE ODER VERWANDTEN VERBINDUNGEN ZUR BEHANDLUNG VON KRANKHEITEN
Title (fr)
COMPOSITIONS POUR ADMINISTRATION ORALE D'ACIDE ZOLÉDRONIQUE OU DE COMPOSÉS ASSOCIÉS POUR LE TRAITEMENT DE MALADIES
Publication
Application
Priority
- US 201314063979 A 20131025
- US 201414279241 A 20140515
- US 2014050427 W 20140808
Abstract (en)
[origin: WO2015060924A1] Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form
IPC 8 full level
A61K 31/663 (2006.01); A61K 9/52 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP KR)
A61K 9/0053 (2013.01 - KR); A61K 9/2004 (2013.01 - EP KR); A61K 31/675 (2013.01 - EP KR); A61P 19/02 (2018.01 - EP); A61P 25/04 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61K 2300/00 (2013.01 - KR)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015060924 A1 20150430; AU 2014340649 B2 20161117; AU 2014340649 C1 20170518; AU 2017200832 A1 20170302; CA 2928350 A1 20150430; CA 2928350 C 20180109; CN 105960240 A 20160921; CN 105960240 B 20180420; CN 108434154 A 20180824; EP 3060220 A1 20160831; EP 3060220 A4 20170531; HK 1257400 A1 20191018; IL 245287 A0 20160630; IL 254123 A0 20171031; JP 2016534081 A 20161104; JP 2017200941 A 20171109; JP 2019059771 A 20190418; JP 2021028343 A 20210225; JP 2022162105 A 20221021; JP 2024040304 A 20240325; JP 6166471 B2 20170719; JP 6453387 B2 20190116; JP 6802245 B2 20201216; JP 7136487 B2 20220913; KR 101739244 B1 20170523; KR 101975687 B1 20190507; KR 20160062177 A 20160601; KR 20170058444 A 20170526; KR 20190009428 A 20190128; MX 2016005396 A 20170301; MY 176246 A 20200724; SG 10201609548U A 20161229; SG 10201800001V A 20180227; SG 11201603042T A 20160530
DOCDB simple family (application)
US 2014050427 W 20140808; AU 2014340649 A 20140808; AU 2017200832 A 20170207; CA 2928350 A 20140808; CN 201480069491 A 20140808; CN 201810150156 A 20140808; EP 14856165 A 20140808; HK 18116608 A 20181226; IL 24528716 A 20160421; IL 25412317 A 20170823; JP 2016526009 A 20140808; JP 2017121884 A 20170622; JP 2018232467 A 20181212; JP 2020196080 A 20201126; JP 2022134019 A 20220825; JP 2024017350 A 20240207; KR 20167012645 A 20140808; KR 20177013050 A 20140808; KR 20197001788 A 20140808; MX 2016005396 A 20140808; MY PI2016701480 A 20140808; SG 10201609548U A 20140808; SG 10201800001V A 20140808; SG 11201603042T A 20140808